Why Does My Protein Elute in the Void Volume on SEC

You load your "pure" protein onto a Superdex 200 column, expecting a nice peak at 70 kDa. Instead, the entire sample elutes in the void volume—the dead space before the column even starts separating. Your protein is either enormous, aggregated, or both. And the purification you thought was done isn't.

The void volume peak is one of the most common and most misinterpreted results in protein biochemistry. Here's what it means and what to do about it.

Key Takeaways

• Void volume = your protein is too large for the column's separation range, either because it's a genuine large complex, an aggregate, or is interacting with the column matrix

• Aggregation is the most common cause—not that your protein is secretly a megadalton complex

• Intrinsically disordered regions inflate apparent size by 1.5–3x, pushing even monomeric proteins into the void

• Column interactions (not just size) can cause void elution: charge repulsion from the matrix pushes proteins through faster

• The fix depends on the cause: aggregation needs construct/buffer redesign; IDR inflation needs SEC-MALS for true MW; column interactions need salt adjustment

What the Void Volume Actually Is

The void volume (V₀) is the volume of buffer between the resin beads—the space that molecules too large to enter any pores pass through without separation.

First check: Is your protein simply larger than the column's range? A 200 kDa complex on a Superdex 75 will always elute in the void. That's not a problem—it's the wrong column.

The Five Causes of Void Volume Elution

Cause 1: Aggregation (Most Common)

Diagnosis:

• Protein was monomeric/oligomeric previously but now elutes in the void

• SDS-PAGE of the void peak shows your protein (not contaminants)

• Dynamic light scattering shows particles >100 nm

Why it happens:

• Concentration-dependent aggregation during loading

• Buffer incompatibility (pH near pI, low ionic strength)

• Freeze-thaw damage

• Oxidation of surface cysteines → disulfide-linked aggregates

• Removal of stabilizing additives (glycerol, arginine, detergent)

Fix:

• Run non-reducing SDS-PAGE: if higher MW bands appear, aggregation is disulfide-mediated → add TCEP

• Lower the loading concentration (<1 mg/mL)

• Add 5% glycerol or 200 mM arginine to the running buffer

• Check pH relative to pI (stay >1.5 units away)

• Filter sample through 0.22 µm before loading to remove large aggregates

Cause 2: Intrinsically Disordered Regions

Diagnosis:

• Protein consistently elutes earlier than expected MW (not just in void—but apparent MW is 2–3x actual)

• AlphaFold model shows long stretches of pLDDT < 50

• SEC-MALS gives true MW matching the monomer, despite early elution

Why it happens:

• Disordered regions adopt extended conformations, increasing the protein's hydrodynamic radius

• SEC separates by size (Stokes radius), not molecular weight

• A 50 kDa protein with a 100-residue disordered tail can have the Stokes radius of a 120 kDa globular protein

Fix:

• Use SEC-MALS to confirm true molecular weight (it measures mass, not size)

• If the IDR isn't needed, truncate it—the structured domain will behave normally on SEC

• This is NOT a problem if you know it's happening—the protein is fine, it just looks big

Cause 3: Non-Specific Column Interactions

Diagnosis:

• Protein elutes in or near the void even though it's well within the separation range

• Changing running buffer salt concentration changes elution position

• Protein elutes normally on a different brand/type of column

Why it happens:

• Some SEC resins have residual charges (slightly negative for agarose-based resins)

• Highly positively charged proteins are repelled from the matrix → elute earlier

• Highly negatively charged proteins may be attracted → elute later (or stick)

• Detergent-solubilized membrane proteins interact with the matrix hydrophobically

Fix:

• Increase NaCl to 300–500 mM in the running buffer (screens charge interactions)

• Try a different resin chemistry (dextran vs agarose vs silica)

• For membrane proteins, ensure sufficient detergent in the buffer (above CMC)

Cause 4: Genuine Large Complex

Diagnosis:

• Protein is known to form a large oligomer or part of a megadalton complex

• SEC-MALS confirms high molecular weight

• Native PAGE shows a single, high-MW band

• The void peak is symmetrical and monodisperse (DLS shows a single population)

This isn't a problem—it's biology. Your protein genuinely forms a large complex.

What to do:

• Switch to a column with a larger separation range (Superose 6 for >600 kDa)

• If you need the monomer, find conditions that dissociate the complex (high salt, different pH, chelating agents for metal-dependent assembly)

Cause 5: Sample Overloading

Diagnosis:

• Void peak appears only when loading >5 mg on a standard analytical column

• Lower loads give a clean peak at the expected position

• The void peak contains your protein plus impurities

Why it happens:

• Column capacity is exceeded—excess protein flows through without entering pores

• Viscosity effects at high concentration distort the separation

Fix:

• Reduce loading to <2% of column volume

• For preparative SEC, use a larger column (HiLoad 16/600 or 26/600)

• Load at <10 mg/mL concentration

The Diagnostic Flowchart

The Bottom Line

The critical tool: SEC-MALS. If you're seeing void volume peaks and you don't have access to multi-angle light scattering, you're guessing. SEC-MALS tells you the actual molecular weight independent of shape, instantly distinguishing aggregation from disorder from genuine complexes.

Diagnosing Aggregation Before SEC

Orbion flags aggregation risk before you reach the column. AstraUNFOLD predicts per-residue disorder probability and amyloidogenicity—identifying regions that drive aggregation when exposed. The PAE Insight Engine reveals domain boundaries, helping you design constructs that exclude disordered tails inflating your Stokes radius. Combined with Bench module protocols optimized for buffer conditions matched to your protein's properties, you can address the root cause rather than troubleshooting at the SEC stage.

References

1. Fekete S, et al. (2014). Theory and practice of size exclusion chromatography for the analysis of protein aggregates. Journal of Pharmaceutical and Biomedical Analysis, 101:161-173. Link

2. Some D, et al. (2019). Characterization of proteins by size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS). Journal of Visualized Experiments, (148):e59615. Link

3. Amartely H, et al. (2018). Coupling multi-angle light scattering to ion exchange chromatography (IEX-MALS) for protein characterization. Scientific Reports, 8:6907. Link